Pharmaceuticals

Revenue of the Pharmaceutical Excipients Market Predicted to Achieve $14867 Billion by 2030, Driven by 6.6% CAGR

February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical excipients market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Pharmaceutical Excipients Market covering 2026–2035?

The pharmaceutical excipients market has experienced robust expansion in recent years. This market is expected to increase from $10822.05 billion in 2025 to $11529.87 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this growth can be attributed to several factors, including the increasing demand for oral formulations, the expansion of pharmaceutical manufacturing in APAC, the adoption of synthetic excipients, stringent regulatory approvals, and rising research and development activities in drug formulation.

The pharmaceutical excipients market size is projected to undergo significant expansion over the next few years. This sector is forecast to reach $14867 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during this period stems from the increasing prevalence of personalized medicine, a rise in biopharmaceutical production, the need for natural and clean-label excipients, technological progress in excipient synthesis, and the broadening reach of contract manufacturing organizations (CMOs). Prominent trends expected in the forecast period include innovative excipient formulations, advanced drug stability solutions, precise targeted drug delivery systems, natural and plant-based excipients, and versatile multi-functional excipients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3415&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Pharmaceutical Excipients Market?

An anticipated increase in biologics sales is projected to boost the pharmaceutical sterility testing market in the future. Biologics, also known as biological products, are medications originating from living organisms, encompassing a diverse range of items like vaccines, blood and its components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Within biologics, pharmaceutical excipients play a crucial role by enhancing stability, refining formulation, and guaranteeing the effective delivery of active biological agents. As an illustration, in October 2024, data from the Generics and Biosimilars Initiative, a Belgium-based entity known for offering quality scientific information on generic and biosimilar medicines, indicated that in addition to the top nine leading biologics, two other complex drugs achieved substantial sales during 2023. Specifically, Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both utilized for type 2 diabetes treatment, generated sales figures of US$14 billion and US$7.2 billion, respectively. Consequently, the expansion in biologics sales is a key factor propelling the pharmaceutical excipients market.

What Leading Segments Are Studied In The Pharmaceutical Excipients Market?

The pharmaceutical excipients market covered in this report is segmented –

1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products

2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities

3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations

Subsegments:

1) By Inorganic Chemicals: Salts, Oxides, Silicates

2) By Organic Chemicals: Sugars, Polymers, Oils And Fats

3) By Other Products: Natural Excipients, Coatings, Antioxidants

Which Innovation Trends Are Advancing Developments Within The Pharmaceutical Excipients Market?

Leading companies in the pharmaceutical excipient market are introducing advanced excipients, such as high-purity variants, to improve drug formulation stability, enhance bioavailability, and support complex drug delivery systems. High-purity excipients are defined as pharmaceutical excipients that have undergone advanced purification processes to eliminate impurities and contaminants. For example, in October 2023, Clariant, a specialty chemical company based in Switzerland, launched three new VitiPure excipients designed to boost the stability and solubility of active pharmaceutical ingredients (APIs). These offerings include VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer with low bioburden. Aimed at various drug delivery applications, especially for sensitive formulations like mRNA vaccines and biologics, these excipients fulfill the growing demand for high-purity ingredients while adhering to strict regulatory standards.

Which Leading Companies Dominate The Pharmaceutical Excipients Market Share?

Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

How Does The Pharmaceutical Excipients Market Perform Across Major Global Regions?

North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmaceutical Excipients Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3415&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Alcohol Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/alcohol-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795